Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Glaser, Ralf W.; | Volk, Hans-Dieter | Liebenthal, Christa | Jahn, Sigbert | Grunow, Roland
Affiliations: Department of Medical Immunology, Medical School (Charité), Humboldt University Berlin, GDR
Note: [] Address reprint requests to: Dr. R.W. Glaser, Inst. Med. Immunologie, Schumannstr. 20/21, Berlin, DDR-1020, GDR. A version of this paper was presented at the First International Conference on Human Antibodies and Hybridomas, Orlando, FI, USA, 18–20 April 1990.
Abstract: Human lymphocytes from peripheral blood (MNC) were separated on magnetic beads for the presence of different surface markers. Cells from positive and negative fractions were successfully immortalized by electro fusion with the heteromyeloma line CB-Fu2. B cells, which were separated on anti-CD 19 coated beads, could be immortalized at a rate between 10−5 and 10−4 even if the fusion was conducted with just a few hundred thousand cells. Comparison of the frequency of 19-positive hybridomas in B cell, T cell, and unseparated MNC fusions indicated that also non-B cells may give rise to HAT resistant hybridoma clones, although the fusion frequency was low.
Keywords: electrofusion, human mononuclear cells, B cells, T cells
DOI: 10.3233/HAB-1990-1206
Journal: Human Antibodies, vol. 1, no. 2, pp. 111-114, 1990
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]